UBS raised the firm’s price target on Celestica (CLS) to $350 from $208 and keeps a Neutral rating on the shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLS:
- Celestica price target raised to $385 from $230 at Stifel
- Celestica price target raised to $305 from $238 at TD Securities
- Celestica price target raised to $370 from $300 at BMO Capital
- Celestica price target raised to $440 from $340 at Goldman Sachs
- Celestica price target raised to $388 from $305 at JPMorgan